174 related articles for article (PubMed ID: 28430385)
1. Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohort.
Knight R; Roux P; Vilotitch A; Marcellin F; Rosenthal E; Esterle L; Boué F; Rey D; Piroth L; Dominguez S; Sogni P; Salmon-Ceron D; Spire B; Carrieri MP;
Addiction; 2017 Sep; 112(9):1669-1679. PubMed ID: 28430385
[TBL] [Abstract][Full Text] [Related]
2. No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort).
Marcellin F; Lions C; Rosenthal E; Roux P; Sogni P; Wittkop L; Protopopescu C; Spire B; Salmon-Ceron D; Dabis F; Carrieri MP;
Drug Alcohol Rev; 2017 Mar; 36(2):227-238. PubMed ID: 27073179
[TBL] [Abstract][Full Text] [Related]
3. Evolution of patients' socio-behavioral characteristics in the context of DAA: Results from the French ANRS CO13 HEPAVIH cohort of HIV-HCV co-infected patients.
Yaya I; Roux P; Marcellin F; Wittkop L; Esterle L; Spire B; Dominguez S; Elegbe BA; Piroth L; Sogni P; Salmon-Ceron D; Carrieri MP;
PLoS One; 2018; 13(7):e0199874. PubMed ID: 29975764
[TBL] [Abstract][Full Text] [Related]
4. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
[TBL] [Abstract][Full Text] [Related]
5. Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus-co-infected patients (ANRS CO13-HEPAVIH).
Nordmann S; Vilotitch A; Roux P; Esterle L; Spire B; Marcellin F; Salmon-Ceron D; Dabis F; Chas J; Rey D; Wittkop L; Sogni P; Carrieri P;
J Viral Hepat; 2018 Feb; 25(2):171-179. PubMed ID: 28984055
[TBL] [Abstract][Full Text] [Related]
6. Short article: Fatigue in the long term after HCV treatment in HIV-HCV-coinfected patients: functional limitations persist despite viral clearance in patients exposed to peg-interferon/ribavirin-containing regimens (ANRS CO13-HEPAVIH cohort).
Marcellin F; Protopopescu C; Poizot-Martin I; Miailhes P; Esterle L; Wittkop L; Spire B; Bocquier A; Salmon-Ceron D; Dabis F; Carrieri MP;
Eur J Gastroenterol Hepatol; 2016 Sep; 28(9):1003-7. PubMed ID: 27177169
[TBL] [Abstract][Full Text] [Related]
7. HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data).
Barré T; Mercié P; Lions C; Miailhes P; Zucman D; Aumaître H; Esterle L; Sogni P; Carrieri P; Salmon-Céron D; Marcellin F;
AIDS Res Ther; 2022 Mar; 19(1):15. PubMed ID: 35292069
[TBL] [Abstract][Full Text] [Related]
8. Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: the role of the physician.
Roux P; Cohen J; Lascoux-Combe C; Sogni P; Winnock M; Salmon-Ceron D; Spire B; Dabis F; Carrieri MP;
Drug Alcohol Depend; 2011 Jul; 116(1-3):228-32. PubMed ID: 21239121
[TBL] [Abstract][Full Text] [Related]
9. HCV-Related Mortality Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort).
Santos ME; Protopopescu C; Sogni P; Yaya I; Piroth L; Bailly F; Marcellin F; Esterle L; Wittkop L; Rosenthal E; Morlat P; Roux P; de Araujo WN; Salmon-Ceron D; Carrieri MP;
AIDS Behav; 2020 Apr; 24(4):1069-1084. PubMed ID: 31286317
[TBL] [Abstract][Full Text] [Related]
10. The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010.
Loko MA; Salmon D; Carrieri P; Winnock M; Mora M; Merchadou L; Gillet S; Pambrun E; Delaune J; Valantin MA; Poizot-Martin I; Neau D; Bonnard P; Rosenthal E; Barange K; Morlat P; Lacombe K; Gervais A; Rouges F; See AB; Lascoux-Combe C; Vittecoq D; Goujard C; Duvivier C; Spire B; Izopet J; Sogni P; Serfaty L; Benhamou Y; Bani-Sadr F; Dabis F;
BMC Infect Dis; 2010 Oct; 10():303. PubMed ID: 20969743
[TBL] [Abstract][Full Text] [Related]
11. HCV Cure and Cannabis Abstinence Facilitate Tobacco Smoking Quit Attempts in HIV-HCV Co-Infected Patients (ANRS CO13 HEPAVIH Cohort Study).
Barré T; Mercié P; Marcellin F; Esterle L; Duvivier C; Teicher E; Bureau M; Chas J; Salmon-Céron D; Sogni P; Carrieri MP; Wittkop L; Protopopescu C;
AIDS Behav; 2021 Dec; 25(12):4141-4153. PubMed ID: 33903998
[TBL] [Abstract][Full Text] [Related]
12. Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH).
Carrieri MP; Serfaty L; Vilotitch A; Winnock M; Poizot-Martin I; Loko MA; Lions C; Lascoux-Combe C; Roux P; Salmon-Ceron D; Spire B; Dabis F;
Clin Infect Dis; 2015 Jul; 61(1):40-8. PubMed ID: 25778750
[TBL] [Abstract][Full Text] [Related]
13. Impact of HCV treatment and depressive symptoms on adherence to HAART among HIV-HCV-coinfected patients: results from the ANRS-CO13-HEPAVIH cohort.
Roux P; Lions C; Cohen J; Winnock M; Salmon-Céron D; Bani-Sadr F; Sogni P; Spire B; Dabis F; Carrieri MP;
Antivir Ther; 2014; 19(2):171-8. PubMed ID: 24166726
[TBL] [Abstract][Full Text] [Related]
14. Self-reported alcohol abuse in HIV-HCV co-infected patients: a better predictor of HIV virological rebound than physician's perceptions (HEPAVIH ARNS CO13 cohort).
Marcellin F; Lions C; Winnock M; Salmon D; Durant J; Spire B; Mora M; Loko MA; Dabis F; Dominguez S; Roux P; Carrieri MP;
Addiction; 2013 Jul; 108(7):1250-8. PubMed ID: 23421419
[TBL] [Abstract][Full Text] [Related]
15. Short article: Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH).
Marcellin F; Protopopescu C; Esterle L; Wittkop L; Piroth L; Aumaitre H; Bouchaud O; Goujard C; Vittecoq D; Dabis F; Salmon-Ceron D; Spire B; Roux P; Carrieri MP;
Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):786-791. PubMed ID: 28418984
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIH.
Salmon D; Bani-Sadr F; Loko MA; Stitou H; Gervais A; Durant J; Rosenthal E; Quertainmont Y; Barange K; Vittecoq D; Shoai-Tehrani M; Alvarez M; Winnock M; Trinchet JC; Dabis F; Sogni P
J Hepatol; 2012 Apr; 56(4):862-8. PubMed ID: 22173166
[TBL] [Abstract][Full Text] [Related]
17. Sleep disturbances in HIV-HCV coinfected patients: indications for clinical management in the HCV cure era (ANRS CO13 HEPAVIH cohort).
Costa M; Rojas TR; Lacoste D; Villes V; Aumaitre H; Protopopescu C; Yaya I; Wittkop L; Krause J; Salmon-Céron D; Marcellin F; Sogni P; Carrieri MP;
Eur J Gastroenterol Hepatol; 2019 Dec; 31(12):1508-1517. PubMed ID: 31094856
[TBL] [Abstract][Full Text] [Related]
18. Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study.
Carrieri MP; Lions C; Sogni P; Winnock M; Roux P; Mora M; Bonnard P; Salmon D; Dabis F; Spire B;
J Hepatol; 2014 Jan; 60(1):46-53. PubMed ID: 23978720
[TBL] [Abstract][Full Text] [Related]
19. Psychiatric and substance use disorders in HIV/hepatitis C virus (HCV)-coinfected patients: does HCV clearance matter? [Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS) HEPAVIH CO13 cohort].
Michel L; Lions C; Winnock M; Lang JP; Loko MA; Rosenthal E; Marchou B; Valantin MA; Morlat P; Roux P; Sogni P; Spire B; Poizot-Martin I; Lacombe K; Lascoux-Combe C; Duvivier C; Neau D; Dabis F; Salmon-Ceron D; Carrieri MP;
HIV Med; 2016 Nov; 17(10):758-765. PubMed ID: 27187027
[TBL] [Abstract][Full Text] [Related]
20. Coffee consumption and reduced self-reported side effects in HIV-HCV co-infected patients during PEG-IFN and ribavirin treatment: results from ANRS CO13 HEPAVIH.
Carrieri MP; Cohen J; Salmon-Ceron D; Winnock M
J Hepatol; 2012 Mar; 56(3):745-7. PubMed ID: 21888878
[No Abstract] [Full Text] [Related]
[Next] [New Search]
